Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ZARS B12
- Development stage
- Unknown
- Lead developer
- Apotex
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
ZARS B12 is a high-potency oral nutritional supplement containing vitamin B12 (cobalamin), developed and marketed by ZARS Pharma. Formulated as a chewable tablet, it is designed to address vitamin B12 deficiency and support hematologic health, specifically red blood cell formation, and neurological function. As a source of exogenous cobalamin, it serves as an essential cofactor for enzymes such as methionine synthase and methylmalonyl-CoA mutase, which are critical for DNA synthesis and myelin maintenance. The product is enlisted with the Drug Regulatory Authority of Pakistan (DRAP) and is positioned as a supportive treatment for anemia and nerve health.
- Brand names
- ZARS B12
- Other names
- Vitamin B12 supplement
02
Targets
RdRp (Coronavirus RNA-dependent RNA polymerase)MMUT (Methylmalonyl-coenzyme A mutase)MTR (Methionine synthase)
Beyond the preview
Go deeper on ZARS B12.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ZARS B12.